Adam James Davenport

Title: Adam James Davenport: Innovator in Calcium Receptor Modulation

Introduction

Adam James Davenport is a notable inventor based in Didcot, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of calcium receptor modulating agents. His work focuses on compounds that can influence the function of the calcium sensing receptor, which is crucial for various physiological processes.

Latest Patents

Davenport holds 1 patent related to his innovative work. His patent, titled "Calcium receptor modulating agents," encompasses compounds represented in Formula I, pharmaceutical compositions comprising them, and methods for treating diseases or disorders associated with the calcium sensing receptor. The invention also details processes for synthesizing these compounds and the intermediates useful in these processes.

Career Highlights

Adam James Davenport is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Amgen allows him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Davenport has collaborated with esteemed colleagues, including Andrew Stewart Tasker and Qing Ping Zeng. These partnerships enhance the research and development efforts in their respective fields.

Conclusion

Adam James Davenport is a prominent figure in the realm of pharmaceutical innovation, particularly in calcium receptor modulation. His contributions through patents and collaborations continue to advance the understanding and treatment of related diseases.